Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Reneo Pharmaceuticals, Inc. | Chief Development Officer | Common Stock | 39.6K | $249K | $6.28 | Aug 28, 2023 | Direct |
Reneo Pharmaceuticals, Inc. | Chief Development Officer | Stock option (right to buy) | 109K | Aug 28, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RPHM | Reneo Pharmaceuticals, Inc. | Aug 28, 2023 | 3 | -$69.9K | 4 | Aug 29, 2023 | Chief Development Officer |
RPHM | Reneo Pharmaceuticals, Inc. | Dec 9, 2022 | 1 | $0 | 4 | Dec 13, 2022 | Chief Development Officer |
RPHM | Reneo Pharmaceuticals, Inc. | Nov 12, 2021 | 2 | $0 | 4 | Nov 15, 2021 | Chief Development Officer |
RPHM | Reneo Pharmaceuticals, Inc. | Oct 11, 2020 | 0 | $0 | 3 | Oct 14, 2021 | Chief Development Officer |